Microgynon 30 ED Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

microgynon 30 ed

bayer new zealand limited - ethinylestradiol 0.03mg; levonorgestrel 0.15mg - tablet - active: ethinylestradiol 0.03mg levonorgestrel 0.15mg excipient: calcium carbonate glycerol glycol montanate iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose titanium dioxide calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose - oral contraception

Microgynon 50 ED Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

microgynon 50 ed

bayer new zealand limited - ethinylestradiol 0.05mg; levonorgestrel 0.125mg - tablet - active: ethinylestradiol 0.05mg levonorgestrel 0.125mg excipient: calcium carbonate glycerol wax e iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone as polyvidone 25,000   purified talc   sucrose titanium dioxide calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose - oral contraception

Microgynon Film Coated Tablet Levonorgestrel 150, Ethinylestradiol 30 Tanzania - angielski - Tanzania Medicinces & Medical Devices Authority

microgynon film coated tablet levonorgestrel 150, ethinylestradiol 30

bayer east africa limited, kenya - levonorgestrel , ethinylestradiol - film coated tablet - levonorgestrel 150, ethinylestradiol 30

MICROGYNON ED Tablets 150,30 mcg Tanzania - angielski - Tanzania Medicinces & Medical Devices Authority

microgynon ed tablets 150,30 mcg

bayer east africa limited, kenya - levonorgestrel , ethinylestradiol - tablets - 150,30 mcg

MICROGYNON Tablet Kenia - angielski - Pharmacy and Poisons Board

microgynon tablet

bayer pharma ag bayer pharma ag 13342 berlin germany - ethinylestradiol / levonorgestrel - tablet - each coated tablet contains 0.030 mg… - hormonal contraceptives: fixed combinations of

TRUST LILY Tablet, Sugar coated 0.15 + 0.030 Tanzania - angielski - Tanzania Medicinces & Medical Devices Authority

trust lily tablet, sugar coated 0.15 + 0.030

renata limited, bangladesh - levonorgestrel , ethinylestradiol - tablet, sugar coated - 0.15 + 0.030

Microgynon Film Coated Tablet ETHINYLESTRADIOL 30 ΜCG + LEVONORGESTREL 150 ΜCG Tanzania - angielski - Tanzania Medicinces & Medical Devices Authority

microgynon film coated tablet ethinylestradiol 30 μcg + levonorgestrel 150 μcg

bayer east africa limited, kenya - levonorgestrel , ethinylestradiol - film coated tablet - ethinylestradiol 30 Μcg + levonorgestrel 150 Μcg

JARDIANCE DUO 12.5 MG500 MG Izrael - angielski - Ministry of Health

jardiance duo 12.5 mg500 mg

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 12.5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

JARDIANCE DUO 12.5 MG500 MG Izrael - angielski - Ministry of Health

jardiance duo 12.5 mg500 mg

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 12.5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.